Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors

Authors :: Wen, S. W. C.
Hansen, T. S.
Nederby, L.
Andersen, R. F.
Nyhus, C. H.
Bertelsen, L.
Sorensen, B. T.
Hager, H.
Hilberg, O.
Jakobsen, A.
Hansen, T. F.
Source :: Wen, S W C, Hansen, T S, Nederby, L, Andersen, R F, Nyhus, C H, Bertelsen, L, Sorensen, B T, Hager, H, Hilberg, O, Jakobsen, A & Hansen, T F 2020, ' Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors ', Annals of Oncology, vol. 31, no. Suppl. 4, 1323P, pp. S853 . https://doi.org/10.1016/j.annonc.2020.08.1637
Publication Year :: 2020

Language :: English
Database :: OpenAIRE
Journal :: Wen, S W C, Hansen, T S, Nederby, L, Andersen, R F, Nyhus, C H, Bertelsen, L, Sorensen, B T, Hager, H, Hilberg, O, Jakobsen, A & Hansen, T F 2020, ' Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors ', Annals of Oncology, vol. 31, no. Suppl. 4, 1323P, pp. S853 . https://doi.org/10.1016/j.annonc.2020.08.1637
Accession number :: edsair.od......3062..a5c88be6e0efb1f4ec5a20bdc9eb9773

Tools